Investment Summary

Parkwalk invested in Reinnervate in December 2010, and after a further funding round the company was sold to Reprocell of Japan in July 2014 for a loss. Parkwalk investors received loss relief on their investment even though the overall cash return to investors in the UK Tech Fund II is positive.

Reinnervate is a market leading company in the fast growing 3D cell culture market. The alvetex® family of 3D cell culture products provides a flexible platform that allows technicians to quickly and easily establish better in vitro assays and models that better mimic in the in vivo growth of cells.

Genuine 3D cell culture – Alvetex has a highly porous and consistent scaffold structure that provides the ideal environment for cells to grow and proliferate in three dimensions. This helps to generate highly effective and reproducible 3D cell growth.